Surgical risk assessment for gynecological oncologic patients

Journal Title: Turkish Journal of Obstetrics and Gynecology - Year 2019, Vol 16, Issue 3

Abstract

Objective: Preoperative surgical risk assessment is important in terms of postoperative morbidity and mortality. Therefore, it is necessary to evaluate the efficacy and safety of these surgeries via an ideal risk assessment model, and reduce risks via applying some findings (for instance, perioperative beta-blockers). There are some risk assessment systems, but these have generally not been verified for patients with gynecologic cancer. The aim of this study was to assess the risk of surgery for gynecological oncologic patients and suggest an easy risk assessment model and risk reduction by applying our findings. Materials and Methods: We retrospectively analyzed 258 gynecologic patients with cancer. Age, diagnosis, staging, performance scale, metoprolol use, heart, renal diabetes, Chronic Obstructive Pulmonary disease, diabetes, operation type and length, carcinoma antigen 125, ascites, albumin, surgical procedure, hospitalization length, and complications were recorded. Results: Of the 258 patients, 173 patients (67.1%) had no complications, 43 patients (16.7%) had one and 42 patients (16.3%) had two or more complications. The most common complication was the acid-base imbalance (14%), followed by urinary tract infection (9.7%). Parameters associated with complications were performance status, ascites, operating length, metoprolol use, and upper abdominal surgery. In our proposed scoring model with a total score range 0-23, cut-off value points for both the presence and rate of complications was found as >5. Conclusion: In gynecological patients with cancer, the addition of metoprolol use and upper abdominal surgery within preoperative risk assessment evaluation parameters are significantly effective in predicting the rate and severity of complications. Moreover, we have suggested a simple, practical, and convenient scoring model for this evaluation.

Authors and Affiliations

Çağlayan Biçer, Jalal Raoufi, Serhan Can İşcan, Mehmet Güney, Evrim Erdemoğlu

Keywords

Related Articles

Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin

Recurrent miscarriage is one of the complications of pregnancy in which the potential role of immunologic factors has already been mentioned. Here, two young women with recurrent miscarriage were consulted in the inferti...

Evaluation inflammatory markers of hemogram parameters in primary ovarian insufficiency

Objective: In most of primary ovarian insufficiency (POI) cases, etiologic factors have not been fully elucidated. Recent studies have revealed that inflammatory agents play an important role in the etiopathogenesis of P...

Systematic review and meta-analysis of ropivacaine use in laparoscopic hysterectomy

To assess the efficacy of all forms of ropivacaine administration for the management of pain and opioid use, specifically in patients undergoing laparoscopic hysterectomy. We searched PubMed, Cochrane CENTRAL, Web of Sci...

Bone recurrence after radical hysterectomy and lymphadenectomy in early-stage cervical cancer

Objective: To present the clinical, surgical, and pathologic features of bone recurrence in patients who underwent radical hysterectomy for early-stage uterine cervical cancer. Materials and Methods: Data of 412 patient...

Role of less commonly agreed risk factors on disease recurrence in endometrial cancer: a propensity score-matched comparison

Objective: To compare the clinicopathologic features of patients with endometrial cancer (EC) with recurrent disease with a primary surgery, stage, grade, and tumor histotype-matched cohort of patients without recurrence...

Download PDF file
  • EP ID EP684617
  • DOI 10.4274/tjod.galenos.2019.93584
  • Views 151
  • Downloads 0

How To Cite

Çağlayan Biçer, Jalal Raoufi, Serhan Can İşcan, Mehmet Güney, Evrim Erdemoğlu (2019). Surgical risk assessment for gynecological oncologic patients. Turkish Journal of Obstetrics and Gynecology, 16(3), -. https://europub.co.uk/articles/-A-684617